Gastritis

• CLINICAL_TRIALS trial_result · 2010-01-13
  Clinical Trial Update: Risk Factors for Gastric Disease in Pediatric Helicobacter Pylori (H. Pylori)

  A completed pediatric clinical trial investigates risk factors for gastric disease associated with Helicobacter pylori infection, including …

• FDA approval · 2009-11-18
  FDA Approved: NIZATIDINE — Original Application (Amneal Pharmaceuticals LLC)

  FDA approves Amneal's nizatidine original application (generic) for use in conditions treated by H2 blockers.

• CLINICAL_TRIALS trial_result · 2009-10-19
  Clinical Trial Update: Bioequivalence of Rebamipide in Korean [NA]

  The study completed an evaluation of bioequivalence for Rebamipide in Korean subjects, addressing therapeutic equivalence and pharmacogeneti…

• FDA approval · 2009-02-27
  FDA Approved: CIMETIDINE 200 ACID REDUCER — Supplemental Application (Walgreen Company)

  FDA approved a supplemental application to approve Walgreens' Cimetidine 200 Acid Reducer as a generic cimetidine product.

• CLINICAL_TRIALS research · 2009-02-05
  Clinical Trial Update: The Revolutions of Helicobacter Pylori Infection, Bacterial Density, and Histological Features After Antrectomy

  A clinical trial update examining how Helicobacter pylori infection, bacterial density, and gastric histology change after antrectomy.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2009-01-21
  FDA Approved: OMEPRAZOLE — Original Application (Sandoz Inc)

  FDA approved the original application for omeprazole from Sandoz Inc, authorizing a generic version of this proton pump inhibitor.

• CLINICAL_TRIALS research · 2007-06-19
  Clinical Trial Update: The Metabolic Contribution of the Human Microbiota to Resting Energy Expenditure

  Clinical trial update examining how the human microbiota contributes to resting energy expenditure. Gastritis is listed as the condition.

• CLINICAL_TRIALS trial_result · 2007-04-04
  Clinical Trial Update: Esomeprazole, Moxifloxacin and Amoxicilin for Rescue Therapy of Helicobacter Pylori Infection [Phase 3]

  Phase 3 trial evaluating a rescue therapy regimen of esomeprazole, moxifloxacin, and amoxicillin for Helicobacter pylori infection and chron…

• FDA approval · 2007-03-16
  FDA Approved: CIMETIDINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

  FDA approved Teva's supplemental application for cimetidine, approving changes to its labeling/indication. This update broadens or clarifies…

• FDA approval · 2006-10-13
  FDA Approved: RANITIDINE — Original Application (Amneal Pharmaceuticals of New York LLC)

  The FDA approved Amneal Pharmaceuticals of New York LLC's original application for generic ranitidine, authorizing its commercial ranitidine…

• CLINICAL_TRIALS research · 2006-09-11
  Clinical Trial Update: Tailored Treatment of H. Pylori Infection Based Polymorphisms of CYP2C19 and 23S rRNA of H. Pylori [Phase 3]

  Phase 3 clinical trial evaluating a tailored treatment strategy for Helicobacter pylori infection based on CYP2C19 and 23S rRNA polymorphism…